Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List -- Stocks to Sell Now. These Read More >>

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced financial results for the three and 12 months ended December 31, 2009, Read More >>

Dr. Reddy's Laboratories, Ltd., an India-based pharmaceutical company, has no plans to sell its stake to GlaxoSmithKline Plc, a UK-b Read More >>

Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has successfully completed the manufacture and transfer of specified material Read More >>

As drug companies face requirements to report all spending on physician-related activity, relationships between thought leaders Read More >>

UK-based pharmaceutical company GlaxoSmithKline, or GSK, has appointed Philippe Fauchet as president of GSK Japan.

Mr Fauchet joins GSK from Sanofi- Read More >>

SmarTrend identified a Downtrend for GlaxoSmithKline (NYSE:GSK) on January 08, 2010 at $40.97. In approximately 4 weeks, GlaxoSmithKline has retu Read More >>

The first Saudi and fourth GCC conference on promoting health is to be held at the InterContinental Jeddah on Read More >>

GlaxoSmithKline plc (ADR) (GSK)

Expected next earnings release:

Announcement date: 4/22/2010 - Before Market

Earnings Quarter: Q1

A
          
            Read More
            >>
          
        

GlaxoSmithKline, one of this region's largest private employers and the foundation of North Carolina's ph Read More >>

Research and Markets (http://www.researchandmarkets.com/research/3d8842/partnering_agreeme) has announced the addition of the "Partnering Agreement Read More >>

Apeiron Biologics has signed an agreement granting GlaxoSmithKline, or GSK, exclusive rights to APN01, an enzyme biotherapeutic currently in Phase I develop Read More >>

Provider of laboratory instruments and solutions The Tecan Group (SWISS: TECN) and Enigma Diagnostics Limited, the decentralised and point-of-care mole Read More >>

GlaxoSmithKline plc (ADR) (GSK)

Expected next earnings release:

Announcement date: 2/4/2010 - Before Market

Earnings Quarter: Q4

An
          
            Read More
            >>
          
        

Biota Holdings Limited (ASX:BTA) today announced that it had received written notification from GlaxoSmithKline that Relenza sales were Read More >>

GlaxoSmithKline plans to eliminate an undisclosed number of employees as the drug maker expands its effo Read More >>

XenoPort, Inc. (Nasdaq: XNPT) announced today that, subject to the approval of the U.S. Food and Drug Administration (FDA), the brand na Read More >>

GlaxoSmithKline today said it had posted a strong performance in a challenging year with a return to sales growth for the first time since 200 Read More >>

Pharmaceutical giant GlaxoSmithKline is about to suffer more setbacks in the ongoing battle of opinions concerning the safety of its much touted diabetes drug Read More >>

GlaxoSmithKline plc (ADR) (GSK)

Expected next earnings release:

Announcement date: 2/4/2010 - Before Market

Earnings Quarter: Q4

An
          
            Read More
            >>
          
        

Apeiron Biologics AG, an Austria-based biotechnology company, has signed an agreement with GlaxoSmithKline plc (GSK), under which GS Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

GlaxoSmithKline plc (ADR) (GSK)

Expected next earnings release:

Announcement date: 2/4/2010 - Before Market

Earnings Quarter: Q4

An
          
            Read More
            >>
          
        

Pharmaceutical giant GlaxoSmithKline (GSK), has decided to freely share its research on potential anti-malaria compounds with researc Read More >>

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer I Read More >>

Drugmaker GlaxoSmithKline, which has cut hundreds of Triangle jobs in the past two years, will announce a Read More >>

Zacks Equity Research highlights Helmerich & Payne (NYSE: HP) as the Bull of the Day and GlaxoSmithKline (NYSE: GSK) the Bear of Read More >>

On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results for the year ended December 31, 2009. It is Read More >>

SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NYSE:GSK) Read More >>

Drug maker GlaxoSmithKline, which has cut hundreds of jobs in the Triangle in recent years, is expected Read More >>

GlaxoSmithKline has reported that the FDA has approved Lamictal XR extended-release tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 y Read More >>

ChemoCentryx has initiated a Phase I clinical trial of CCX168, an orally-administered small molecule designed to treat autoimmune diseases. The initiation o Read More >>

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the sec Read More >>

Research and Markets(http://www.researchandmarkets.com/research/e47fdb/ophthalmic_pharmac) has announced the addition of the "Ophthalmic Pharmaceut Read More >>

Research and Markets(http://www.researchandmarkets.com/research/242815/sports_and_fitness) has announced the addition of the "Sports and Fitness Nu Read More >>

GlaxoSmithKline (NYSE:GSK) reported on Friday the grant of accelerated approval from the US Food and Drug Administration (FDA) for a new combination re Read More >>

GlaxoSmithKline, or GSK, has reported that the FDA has granted accelerated approval for a new combination regimen using Tykerb as a first-line, all-oral tre Read More >>

GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combin Read More >>

GlaxoSmithKline (NYSE: GSK) announced today that the U. Read More >>

Zacks.com releases the latest Industry Outlook. Today, Zacks Equity Research discusses the Pharma & Biotech Industry, including GlaxoSmithKline Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

Franklin Circuit Judge Roger Crittenden has awarded Kentucky more than $5.8 million in civil penalt Read More >>

Amgen, Inc. has signed an agreement with Stiefel Laboratories, Inc., a subsidiary of GlaxoSmithKline plc, to promote Amgen's anti-in Read More >>

SmarTrend identified a Downtrend for GlaxoSmithKline (NYSE:GSK) on January 08, 2010 at $40.97. In approximately 3 weeks, GlaxoSmithKline has retu Read More >>

Research and Markets (http://www.researchandmarkets.com/research/eea70b/sports_and_fitness) has announced the addition of the "Sports and Fit Read More >>

Research and Markets (http://www.researchandmarkets.com/research/2db97b/ophthalmic_pharmac) has announced the addition of the "Ophthalmic Pha Read More >>

GlaxoSmithKline plc (ADR) (GSK)

Expected next earnings release:

Announcement date: 2/4/2010 - Before Market

Earnings Quarter: Q4

An
          
            Read More
            >>